Burger King is positioning itself in front of a major trend that will be taking place in the US dining world because of the increasing number of Americans taking GLP-1-based weight loss drugs, including Ozempic, Wegovy, Zepbound, and Mounjaro. Although the famous Whopper continues to sell well, Burger King is secretly experimenting with smaller meat-filled burgers.
In a recent interview, Tom Curtis, President of Burger King U.S. and Canada, acknowledged the potential disruption.
“My impulse has always been that this GLP-1 movement is going to have a profound impact on the industry,”
Curtis said.
“We haven’t seen it yet, so I keep telling the team we need to be prepared for this.”
Burger King’s new products include Whopper Bites and bowls that consist of more protein ingredients. The new product development intends to provide customers with more variety in terms of smaller portions since those people prefer to consume less but keep their muscle mass intact due to high protein content. Curtis stated that at present, there are no issues with Whopper sales, and the changes are taken in advance, not because of any problems.
GLP-1 pills have an effect on suppressing appetite and providing the sensation of satiety by slowing down the digestion process. Their rapid popularity has forced restaurants across the country to rethink their menus. According to Gallup polls, about 11% of American adults use such medications almost four times more frequently compared to two years ago. People consuming these pills try to avoid eating fast food and opt for small portion size and nutrients.
It is worth noting that this tendency does not apply only to Burger King. Companies including Chipotle, Olive Garden, Shake Shack, Subway, Jack in the Box, and Smoothie King have adjusted their menus.
As GLP-1 use continues climbing, fast-food menus could look noticeably different in coming years more flexible portions, emphasis on protein, and options that appeal to both traditional customers and those managing smaller appetites. Burger King’s approach highlights a broader industry pivot: adapting without abandoning core items that built the brand.
Whether these drugs permanently reshape dining habits or simply expand choices remains to be seen. For now, Burger King is betting that preparation today will keep the flame grilled and the customers coming back.
